← Back to Clinical Trials
Recruiting Phase 1 NCT07007520

NCT07007520 A Study to Evaluate the Food Effect on the Pharmacokinetics of DA-5223 in Healthy Adult Subjects

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07007520
Status Recruiting
Phase Phase 1
Sponsor Dong-A ST Co., Ltd.
Condition Healthy Adult
Study Type INTERVENTIONAL
Enrollment 38 participants
Start Date 2025-11
Primary Completion 2025-11

Trial Parameters

Condition Healthy Adult
Sponsor Dong-A ST Co., Ltd.
Study Type INTERVENTIONAL
Phase Phase 1
Enrollment 38
Sex ALL
Min Age 19 Years
Max Age 55 Years
Start Date 2025-11
Completion 2025-11
Interventions
DA-5223(Fasting)DA-5223(Fed)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study will evaluate the food effect on the pharmacokinetics of DA-5223 in healthy adult subjects

Eligibility Criteria

Inclusion Criteria: * Adult male or female, 19 years to 55 years * Male weighing 50 kg or more, female weighing 45 kg or more with a body mass index (BMI) of 18.0 kg/m2 to 30.0 kg/m2 * The subjects signed and dated informed consent form after hearing a detailed explanation of the study, fully understanding and determined voluntarily to participate Exclusion Criteria: * The subjects with acute illness * The subjects with a history of gastrointestinal disease or surgery that may affect the absorption of Investigational Product * The subjects hypersensitive to any of the Investigational Product components or other drug components * The subjects who have continuously consumed excessive smoking or alcohol within 6 months of screening, or who cannot stop smoking, caffeine, or alcohol intake during hospitalization * The subjects who are pregnant or lactating

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology